We discovered significantly different pathogenic germline mutations of TP53, BRCA2, and RECQL4 in ESCC cohorts, and we clarified the association between double-hit events and diagnosis age in patients with ESCC. The gene discussed is RECQL4; the disease is esophageal squamous cell carcinoma.